These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28049656)

  • 1. HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study.
    Mutharasan RK; Thaxton CS; Berry J; Daviglus ML; Yuan C; Sun J; Ayers C; Lloyd-Jones DM; Wilkins JT
    J Lipid Res; 2017 Mar; 58(3):600-606. PubMed ID: 28049656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study.
    Virani SS; Catellier DJ; Pompeii LA; Nambi V; Hoogeveen RC; Wasserman BA; Coresh J; Mosley TH; Otvos JD; Sharrett AR; Boerwinkle E; Ballantyne CM
    Atherosclerosis; 2011 Dec; 219(2):596-602. PubMed ID: 21868017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of Smaller High-Density Lipoprotein Particle (HDL-P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA).
    Kim DS; Li YK; Bell GA; Burt AA; Vaisar T; Hutchins PM; Furlong CE; Otvos JD; Polak JF; Arnan MK; Kaufman JD; McClelland RL; Longstreth WT; Jarvik GP
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein particle concentration and subclinical atherosclerosis of the carotid arteries in Japanese men.
    Zaid M; Fujiyoshi A; Miura K; Abbott RD; Okamura T; Takashima N; Torii S; Saito Y; Hisamatsu T; Miyagawa N; Ohkubo T; Kadota A; Sekikawa A; Maegawa H; Nakamura Y; Mitsunami K; Ueshima H;
    Atherosclerosis; 2015 Apr; 239(2):444-50. PubMed ID: 25687270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
    Ogura M; Hori M; Harada-Shiba M
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein concentration, particle number, size and cholesterol efflux capacity are associated with mitochondrial oxidative stress and function in an HIV positive cohort.
    Parikh NI; Gerschenson M; Bennett K; Gangcuangco LM; Lopez MS; Mehta NN; Playford MP; Nakamoto BK; Seto TB; Chow DC; Shikuma CM
    Atherosclerosis; 2015 Mar; 239(1):50-4. PubMed ID: 25574857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL cholesterol efflux capacity and incident cardiovascular events.
    Rohatgi A; Khera A; Berry JD; Givens EG; Ayers CR; Wedin KE; Neeland IJ; Yuhanna IS; Rader DR; de Lemos JA; Shaul PW
    N Engl J Med; 2014 Dec; 371(25):2383-93. PubMed ID: 25404125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL size is more accurate than HDL cholesterol to predict carotid subclinical atherosclerosis in individuals classified as low cardiovascular risk.
    Parra ES; Panzoldo NB; Zago VH; Scherrer DZ; Alexandre F; Bakkarat J; Nunes VS; Nakandakare ER; Quintão EC; Nadruz W; de Faria EC; Sposito AC
    PLoS One; 2014; 9(12):e114212. PubMed ID: 25470778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk.
    Yokoyama K; Tani S; Matsuo R; Matsumoto N
    Heart Vessels; 2019 Feb; 34(2):227-236. PubMed ID: 30140959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players.
    Virani SS; Pompeii L; Lincoln AE; Dunn RE; Tucker AM; Nambi V; Nasir K; Vogel RA; Boone JL; Roberts AJ; Ballantyne CM
    Atherosclerosis; 2012 Jun; 222(2):551-6. PubMed ID: 22525822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small and medium sized HDL particles are protectively associated with coronary calcification in a cross-sectional population-based sample.
    Ditah C; Otvos J; Nassar H; Shaham D; Sinnreich R; Kark JD
    Atherosclerosis; 2016 Aug; 251():124-131. PubMed ID: 27318832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis.
    Mehta NN; Li R; Krishnamoorthy P; Yu Y; Farver W; Rodrigues A; Raper A; Wilcox M; Baer A; DerOhannesian S; Wolfe M; Reilly MP; Rader DJ; VanVoorhees A; Gelfand JM
    Atherosclerosis; 2012 Sep; 224(1):218-21. PubMed ID: 22858285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
    Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
    Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
    Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: a community-based cohort study.
    Qi Y; Fan J; Liu J; Wang W; Wang M; Sun J; Liu J; Xie W; Zhao F; Li Y; Zhao D
    J Am Coll Cardiol; 2015 Feb; 65(4):355-363. PubMed ID: 25634834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
    Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.
    Ahmed MO; Byrne RE; Pazderska A; Segurado R; Guo W; Gunness A; Frizelle I; Sherlock M; Ahmed KS; McGowan A; Moore K; Boran G; McGillicuddy FC; Gibney J
    Diabetologia; 2021 Mar; 64(3):656-667. PubMed ID: 33169205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.
    Otvos JD; Guyton JR; Connelly MA; Akapame S; Bittner V; Kopecky SL; Lacy M; Marcovina SM; Muhlestein JB; Boden WE
    J Clin Lipidol; 2018; 12(2):348-355.e2. PubMed ID: 29409728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.